The page could not be loaded. The CMS.gov Web site currently does not fully support browsers with
Prolotherapy, Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents
The medical effectiveness of the above therapies has not been verified by scientifically controlled studies. Accordingly, reimbursement for these modalities should be denied on the ground that they are not reasonable and necessary as required by §1862(a)(1) of the Act.
9/27/1999 - Issued decision memo maintaining national noncoverage policy.
This NCD has been or is currently being reviewed under the National Coverage
Determination process. The following are existing associations with NCAs, from the National
Coverage Analyses database.